Web Results

Mecasermin

en.wikipedia.org/wiki/Mecasermin

Mecasermin (INN) (trade name Increlex) is recombinant human insulin-like growth factor 1 (IGF-I), which is used for the long-term treatment of growth failure in ...

Mecasermin: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/mecasermin.html

May 2, 2016 ... Easy to read patient leaflet for mecasermin. Includes indications, proper use, special instructions, precautions, and possible side effects.

Mecasermin (Subcutaneous Route) Description and Brand Names ...

www.mayoclinic.org/drugs-supplements/mecasermin-subcutaneous-route/description/drg-20068117

Apr 1, 2015 ... Mecasermin injection is a man-made version of insulin-like growth factor-1 (IGF-1 ) hormone. IGF-1 is produced in the liver and plays an ...

DrugBank: Mecasermin

www.drugbank.ca/drugs/DB01277

May 16, 2007 ... Mecasermin contains recombinant-DNA-engineered human insulin-like growth factor-1 (rhIGF-1). IGF-1 consists of 70 amino acids in a single ...

DailyMed - INCRELEX- mecasermin injection, solution

dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8b27a1b-a611-4f91-ad22-76d4b390c3ae

1.1 Severe Primary IGF-1 Deficiency (Primary IGFD) INCRELEX® (mecasermin [ rDNA origin] injection) is indicated for the treatment of: growth failure in .

Mecasermin (Increlex®) - Texas Medicaid/CHIP Vendor Drug Program

www.txvendordrug.com/downloads/criteria/mecasermin.pdf

Mecasermin (Increlex®). [Developed, December 2006; Revised, May 2007; May 2010; June 2010; February 2012; December 2013]. MEDICAID DRUG USE ...

Insulin-Like Growth Factor-1 (IGF-1) Analogues: Mecasermin ... - Aetna

www.aetna.com/cpb/medical/data/700_799/0711.html

Aetna considers mecasermin (Increlex) and mecasermin rinfabate (Iplex)* medically necessary for the treatment of growth failure in children with severe primary ...

INCRELEX, INN: mecasermin - European Medicines Agency

www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000704/WC500032222.pdf

INCRELEX (mecasermin) is recombinant human insulin-like growth factor-1 ... Mecasermin was granted orphan status in the EU for “Treatment of growth ...

Increlex (mecasermin) Drug Side Effects, Interactions, and ...

www.emedicinehealth.com/drug-mecasermin/article_em.htm

Drug information on Increlex (mecasermin), includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid.

Mecasermin - US Family Health Plan

www.usfamilyhealth.org/wp-content/uploads/2011/07/PAFC_MECASERMIN20070801.pdf

Mecasermin [rDNA origin] injection (Increlex) is used for the long-term treatment of growth failure in children with severe primary insulin-like growth factor (IGF)-1  ...

More Info

Increlex (mecasermin) - CenterWatch

www.centerwatch.com

Increlex (mecasermin): For the treatment of growth failure due to Primary IGFD. New approved drug details including side effects, uses and general information.

Increlex

www.increlex.com

Manufacturer's information about recombinant human insulin-like growth factor-1, marketed under the brand name Increlex (generic name mecasermin).

Mecasermin (recombinant human insulin-like growth factor I). - NCBI

www.ncbi.nlm.nih.gov

Adv Ther. 2009 Jan;26(1):40-54. doi: 10.1007/s12325-008-0136-5. Epub 2009 Jan 28. Mecasermin (recombinant human insulin-like growth factor I).